Pharma drug development only for wealthy countries?


Pharma drug development only for wealthy countries?

“Bayer is effectively admitting that the drugs they develop are deliberately going to be rationed to the wealthiest patients. This is a side-effect of the way drugs are developed today. Pharmaceutical companies are singularly focused on profit and so aggressively push for patents and high drug prices,” said Dr Manica Balasegaram, Executive Director of MSF’s Access Campaign. (CLICK THE PICTURE OF “BAYER” REPRESENTATIVE IN INDIA TO READ THE ARTICLE OF “iNDIA tIMES”

Anuncios

Etiquetas: , ,

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s


A %d blogueros les gusta esto: